T1	Intervention 685 783	Vaccinees were bled immediately prior to each vaccination, and again at 3- and 12-month follow-up.
T2	Intervention 623 683	Three vaccine doses were administered at 8-12 week intervals
T3	Intervention 401 622	four vaccine groups as follows: 68 received BCG plus killed promastigotes (group A), 47 received BCG alone (group B), 47 received killed promastigotes alone (group C), and 46 formed the diluent control (placebo, group D).
T4	Intervention 784 868	Skin tests were performed prevaccination, and again at the 3- and 12-month follow-up
